Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers elucid.com

Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE………………